Biobanking News
-
Lifespin Announces Expansion of Laboratory Testing Capability
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced today that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual laboratory testing capacity. Lifespin will now be able to scan and create the corresponding digitized, quantitative metabolic profiles involving as many as 300,000 human samples ...
-
DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language ...
-
Recognizing 10 years of philanthropic support for prostate cancer research
Two powerhouse researchers in prostate cancer will change the way we treat the disease, thanks to funding from legendary volunteer fundraisers, the Bird Dogs and the Alberta Cancer Foundation. Working with the Alberta Cancer Foundation and the University of Alberta, the Bird Dogs have enabled a new one-term, five-year chair position to further prostate cancer research — the Bird Dogs ...
-
KSM research and innovation center and Valo Health announce first of its kind multiyear collaboration to spearhead preventive care and personalized medicine for patients
Kahn-Sagol-Maccabi (KSM), the research and innovation center of Israel’s leading HMO — Maccabi Healthcare Services, and Valo Health, Inc. (“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric ...
-
Lifespin Launches Commercial Access to its Metabolic Profiler Software and Database for Pharma and Biobank Services
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced today that it has launched a new commercial service for the pharmaceutical and biobanking industry to assist companies in key phases of research, development, and manufacturing. Immediate applications of Lifespin’s commercial services, which leverages access to Lifespin’s proprietary ...
-
CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
Centogene N.V. (Nasdaq: CNTG), the commercial-stage, essential biodata life science partner for rare and neurodegenerative diseases, today announced the appointment of Miguel Coego Rios as Managing Director and Chief Financial Officer of the Company, effective June 22, 2022. “As we continue to make progress on pivoting the organization to focus on Core Business execution, we are very ...
-
CHA Medical & Bio Group Announces Groundbreaking for Its New Cell Gene Biobank Facility
CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea. Investing over $250 million in the project, the new 710,000 ft2 site will comprise one of the world’s largest single facilities for cell and gene therapy manufacturing and advanced stem cell biobanking. The construction of the state-of-art facility is expected to be ...
-
Melbourne Awards celebrate city’s best and brightest
Lord Mayor Sally Capp said 2021’s finalists have gone above and beyond to make our city better. “We’re thrilled to recognise and celebrate the inspirational people who are making invaluable contributions to our city,” the Lord Mayor said. “It’s the people that make our city the wonderful place it is, and the Melbourne Awards finalists are a testament to our ...
-
Immunai Raises $60M to Reprogram Immunity
Immunai, a New York and Tel Aviv based biotech company, announced today $60M in funding, increasing the company’s total funding-to-date to over $80M. Immunai integrates multi-omic single-cell analytics and machine learning to identify novel immunological insights that lead to the discovery and development of more effective and targeted immunotherapies. The Series A round was led by ...
By Immunai
-
Longenesis announces Curator platform for privacy-preserving data use for COVID-19 research
Longenesis - a digital health startup aiming towards the acceleration of the biomedical research pipeline worldwide, announced a release of its product Curator. It is a platform where clinical institutions and patient organizations are connected in consortiums with potential collaboration partners and study sponsors to initiate further cooperation. The main difference between existing solutions - ...
By Longenesis
-
Thermo Fisher Scientific Expands Clinical Supply Chain Services in Europe
To meet accelerating demand for robust clinical supply chain services throughout Europe, Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany. The new sites will bring much-needed clinical supply chain continuity and specialized cold chain and cryogenic expertise across Europe and globally. Today's ...
-
Thermo Fisher Scientific Further Expands Laboratory Plastics Production to Support COVID-19 Testing, Therapies and Vaccines
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is investing more than $140 million to further expand its laboratory plastics consumables production to support significant global demand for COVID-19 testing, as well as development and manufacturing of therapies and vaccines. "Early in the pandemic, we quickly joined forces with governments, ...
-
Longenesis enters the Singapore market as a participant of 500 Startups Singapore program to accelerate healthcare research in the region
Longenesis joins the 500 Startups family in a 16-week Singapore-based program designed to accelerate the growth of the best-selected startups through deep market insights, hands-on coaching and exposure to 500’s network of partners, experts, and talent. For the next 4 months, our team will be fully immersed in the Singapore market leveraging the 500 Startups’ network to multiply the ...
By Longenesis
-
Official Opening of Service Laboratory
Bio-Me, a pioneer in rapid gut microbiome analysis is announcing the opening of its gut microbiome analysis service laboratory. This will enable the Research & Development departments worldwide to access their Precision Microbiome Profiling (PMP™) platform. The service laboratory is located at the Oslo’s Science Park’s premier lab sharing facility, the ShareLab. The lab ...
By Bio-Me
-
A2LA Accredits Cornell Veterinary Biobank to New ISO 20387 International Standard
A2LA is proud to announce the issuance of its first accreditation, and the first such accreditation in the world, to the newly published standard ISO 20387:2018 – Biobanking – General requirements for biobanking. ISO 20387 contains requirements designed to demonstrate the competence of a biobank’s operation and ability to provide biological material and associated data for ...
-
Thermo Fisher Scientific Launches Axiom Microbiome Array for Research
Thermo Fisher Scientific, the world leader in serving science, recently launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples. Developed in collaboration with the Lawrence Livermore National Laboratory (LLNL), the array is designed to increase the understanding of microorganisms, while ...
-
ID Genomics Social Purpose Corporation Report, 2018
Antimicrobial resistance threatens the very core of human healthcare. ID Genomics’ Social Purpose is simple: to limit bacterial resistance and preserve antibiotics for the good of mankind. We believe that antimicrobial resistance connects every human on the planet and that everyone has a right to be protected from this threat. While our core business focuses on developing diagnostics to ...
-
First recipients of research grants to support genomic studies in Africa announced
African scientists will conduct genomic research on kidney disease, diabetes, heart disease, obesity, tuberculosis and African sleeping sickness through inaugural grants of the Human Heredity and Health in Africa Consortium (H3Africa). The grants were announced by the two funding organizations, the U.S. National Institutes of Health and the Wellcome Trust, a global charity based in London. The ...
-
Frost & Sullivan Recognizes Thermo Fisher Scientific for its Superiority in the Global Biobanking Products, Services and Solutions Market
Based on its recent analysis of the integrated biobanking solutions market, Frost & Sullivan recognizes Thermo Fisher Scientific, the world leader in serving science, with the 2011 Global Frost & Sullivan Award for Company of the Year. Thermo Fisher is the world's largest provider of biobanking products, services and solutions, enabling its customers to make the world healthier, cleaner ...
-
EU allergy and asthma network marks its achievements
The Global Allergy and Asthma European Network (GA2LEN)1, established in 2005 to facilitate excellence in allergy research across clinical and research institutions in Europe, has recently published a report on its major achievements. Funded by the EU, GA2LEN is composed of a multidisciplinary research network centred on scientific projects in allergy and asthma. It integrates research on ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you